The European Commission and most EU states recently signed a huge contract with US pharmaceutical firm Gilead for its anti-corona drug Remdesivir.
But the World Health Organisation (WHO) says there is no evidence the medicine works.
The price was sky high - 420 times what it costs to produce the drug.
And there is little transparency for the EU taxpayer on how the Gilead deal came about or how much money might have been wasted.
The WHO recently said that there was n...
Back our independent journalism by becoming a supporting member
Already a member? Login hereThis article is part of the investigation #BehindThePledge given financial support from Journalismfund.eu and IJ4EU. Lise Barnéoud, Lucien Hordijk, Hristio Boytchev, Ludovica Jona, and Priti Patnaik also contributed reporting
This article is part of the investigation #BehindThePledge given financial support from Journalismfund.eu and IJ4EU. Lise Barnéoud, Lucien Hordijk, Hristio Boytchev, Ludovica Jona, and Priti Patnaik also contributed reporting